Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2013 1
2015 2
2016 2
2018 1
2019 1
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
[Possibilities and limitations of eye drops for glaucoma therapy].
Lanzl IM, Poimenidou M, Spaeth GL. Lanzl IM, et al. Ophthalmologe. 2016 Oct;113(10):824-832. doi: 10.1007/s00347-016-0332-7. Ophthalmologe. 2016. PMID: 27604586 Review. German.
BACKGROUND: In Germany, chronic open-angle glaucoma is mostly treated by daily eye drop application. The possibilities and limitations of this form of therapy are presented. ...However, restrictions induced by patients due to inadequate adherence or by the drug due …
BACKGROUND: In Germany, chronic open-angle glaucoma is mostly treated by daily eye drop application. The possibilities and lim …
Chitosan beads coated with almond and walnut shells for the adsorption of gatifloxacin antibiotic compound from aqueous solutions.
Dutta J, Mala AA, Kyzas GZ. Dutta J, et al. Environ Sci Pollut Res Int. 2023 Feb;30(9):23553-23567. doi: 10.1007/s11356-022-23892-y. Epub 2022 Nov 3. Environ Sci Pollut Res Int. 2023. PMID: 36327083
In the present study, chitosan (C), walnut (W), and almond shell (A) powder adsorbent (in different combinations as almond shells:walnut:chitosan 2:1:1 (AWC), chitosan:almond shell:walnut 2:1:1 (CAW), and walnut:almond shells:chitosan 2:1:1 (WAC)) powd …
In the present study, chitosan (C), walnut (W), and almond shell (A) powder adsorbent (in different combinations as almond shells: …
[Walnut-shell moxibustion for dry eye symptoms: a randomized controlled trial].
Fu W, Zhang G, Liu Z, Wu L, Xu J. Fu W, et al. Zhongguo Zhen Jiu. 2018 Nov 12;38(11):1177-82. doi: 10.13703/j.0255-2930.2018.11.012. Zhongguo Zhen Jiu. 2018. PMID: 30672198 Clinical Trial. Chinese.
OBJECTIVE: To evaluate the effects of walnut-shell moxibusiton on dry eye symptoms. METHODS: A total of 67 patients with dry eye symptoms were randomized into a walnut moxibustion group and a sodium hyaluronate eye drops group. ...In the sodium …
OBJECTIVE: To evaluate the effects of walnut-shell moxibusiton on dry eye symptoms. METHODS: A total of 67 patients with dry …
Injection volume and intracameral moxifloxacin dose.
Shorstein NH, Gardner S. Shorstein NH, et al. J Cataract Refract Surg. 2019 Oct;45(10):1498-1502. doi: 10.1016/j.jcrs.2019.04.020. Epub 2019 Aug 20. J Cataract Refract Surg. 2019. PMID: 31444079 Free PMC article.
PURPOSE: To test the effect of injection volume and concentration on dosing and residence time of moxifloxacin in the anterior chamber (AC). SETTING: Kaiser Permanente, Walnut Creek, California, USA. DESIGN: Experimental study. METHODS: Moxifloxacin 0.5%/0.05 mL, moxifloxa …
PURPOSE: To test the effect of injection volume and concentration on dosing and residence time of moxifloxacin in the anterior chamber (AC). …
The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes.
Shiuey EJ, Mehran NA, Ustaoglu M, Zhang Q, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D. Shiuey EJ, et al. Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):967-974. doi: 10.1007/s00417-021-05410-x. Epub 2021 Sep 22. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34550421
PURPOSE: To evaluate the efficacy and safety profile of netarsudil 0.02% ophthalmic solution in a tertiary glaucoma referral center. METHODS: This retrospective cohort study included patients with glaucoma initiated on netarsudil 0.02% at a single institution from November …
PURPOSE: To evaluate the efficacy and safety profile of netarsudil 0.02% ophthalmic solution in a tertiary glaucoma referral center. …
The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center.
Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Pro MJ, Lee D. Wong JC, et al. Graefes Arch Clin Exp Ophthalmol. 2023 Jan;261(1):193-200. doi: 10.1007/s00417-022-05780-w. Epub 2022 Jul 29. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 35904596
PURPOSE: To assess real-world effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% (FCNL) in management of glaucoma patients in a tertiary eye care center. METHODS: This retrospective cohort study included glaucoma patients initiated …
PURPOSE: To assess real-world effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% (FCNL) in managem …
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Shorstein NH, Winthrop KL, Herrinton LJ. Shorstein NH, et al. J Cataract Refract Surg. 2013 Jan;39(1):8-14. doi: 10.1016/j.jcrs.2012.07.031. Epub 2012 Oct 2. J Cataract Refract Surg. 2013. PMID: 23036356
During 2008 and 2009, in addition to the surgeons' usual postoperative topical drop regimen, patients received intracameral cefuroxime unless contraindicated by allergy or posterior capsule rupture (PCR). ...
During 2008 and 2009, in addition to the surgeons' usual postoperative topical drop regimen, patients received intracameral cefuroxim …
11 results